Skip to main content

He Eye Specialist Hospital (HESH): new full WAEH member

December 21, 2022

He Eye Specialist Hospital Group was founded by Dr He Wei, a professor, chief physician, doctor of medicine, and doctoral supervisor, who returned to his home country after finishing his overseas study. Vice President of the National Prevention of Blindness Technical Guidance Committee, Board member of the Ophthalmology Foundation. His team is a group chain medical institution that integrates medical teaching and research, adopts a tertiary eye care service model, and is committed to eye health management through the whole life cycle.

On March 22, 2022, He Eye Specialist Hospital Group made its initial public offering on the Shenzhen Stock Exchange and was listed on the GEM (301103. SZ).

With the mission of “He Eye care services to everyone”, He’s Eye Care adheres to the development concept of “Technology & Compassion”, insists on prevention-oriented and combined prevention and treatment, and provides ophthalmology and optometry services for eye disease patients. We have rich clinical experience and outstanding technical advantages in cataract, glaucoma, vitreoretinopathy, dry eye, Chinese medicine, refractive error and other treatment services.

Dr He Wei and his team have introduced phacoemulsification, vitrectomy and fundus laser technology since the early days of their business in 1995. At the same time, they were using innovative technology to establish and improve He Eye’s characteristic tertiary eye health medical service model. Currently, the model is based on Internet technology and integrates online and offline resources, enabling offline services to continuously extend to pre-consultation, consultation and post-consultation, building a medical service system centred on personal eye health and effectively supporting the continuous and rapid development of the business.

Given the comprehensive ability of the medical technology team, medical service capacity and level, medical quality, scientific research and teaching, Shenyang He Eye Specialist Hospital, the central hospital of the Group, was awarded as “National Key Clinical Specialties” and is also the “Training Base for Prevention and Treatment of Blindness” of the National Health Care Commission. “Ltd., the training base for ophthalmologists of the International Council of Ophthalmology and the national drug clinical trial institution, Shenyang He Eye Specialist Hospital. is an ISO9001 international quality management system certificated unit.

Proactive social responsibility is the embodiment of He Eye Specialist Hospital’s value of “Work with a common purpose “. With a high sense of responsibility and mission, He Eye Specialist Hospital practices social responsibility by promoting advocacy, education, training, and public welfare and others, becoming an important force in promoting the development of eye health. He Eye Specialist Hospital has been awarded the “People’s Corporate Social Responsibility Award” by People’s Daily Online and “the 2020 Demonstration Project for People’s Livelihood” by the national government. The company has also been listed on the United Nations Global Compact China Network’s “Corporate Best Practice” list.

In the future, He Eye Specialist Hospital will keep up with the time, persist in technological innovation, accelerate talent training, promote regional layout, strengthen international cooperation, fulfil social responsibility, and continue to provide high-quality eye care services for the people.

Want to know more about this eyehospital? Go to: https://hevisiongroup.com

Older news


More recent

Glaucoma Insights course

News from our full member St. Erik Eye Hospital On 26 – 27 November, the St. Erik Eye Hospital is hosting the Glaucoma Insights Course in Stockholm. It is an intensive two-day course offering a rare opportunity to meet, learn from and discuss clinical challenges directly with seven internationally leading glaucoma experts. There are still […]

New Moorfields stem cell treatment improves vision for untreatable condition

News from our full member Moorfields Eye Hospital A new breakthrough stem cell treatment for ARK (aniridia-related keratopathy) has seen patients’ vision improve for this previously untreatable rare genetic eye condition in a first-in-human clinical trial at Moorfields Eye Hospital and the UCL Institute of Ophthalmology, published in JAMA Ophthalmology. Aniridia is a surface disorder […]

Newsletter WAEH | May 2026

Join the WAEH 20th Annual Meeting! 🎉Our 20th Annual Meeting is coming up, and this year we are celebrating our Jubileum Year! This year the meeting will be in São Paulo (Brazil) from 9 – 13 November to share best practices in eye hospitals worldwide. There will also be facultative visits to Londrina (Brazil) and […]

Newsletter WAEH | April 2026

20th Annual Meeting: send in your proposals now! 🎉Our 20th Annual Meeting is coming up, and this year we are celebrating our Jubileum Year! This year the board meeting will be in São Paulo from 9-13 November to share best practices in eye hospitals worldwide. There will also be facultative visits to Londrina (Brazil) and […]

Newsletter WAEH | July

WAEH Community of Practice FAIR Images in Ophthalmology | 27 August 2026 FAIR data stands for Findable, Accessible, Interoperable, and Reusable. These are principles for managing, storing, and publishing research data in such a way that both humans and computers can easily find, understand, and reuse them, making scientific research more efficient and reliable. This […]